Imunon, Inc. (IMNN) AI Dilution Summary

The company is funding itself through its active at-the-market program with H.C. Wainwright & Co., LLC, authorised to $17,000,000 with $4,797,848 sold to date. Cash was $6,864,378 at 2026-06-30 against estimated monthly burn of $1,168,439, and the company raised $10,000,000 gross in a private placement of preferred stock and notes that closed 2026-06-03. Dilution here is driven primarily by the $12,202,152 of remaining ATM capacity.